Molecular characterization and antimicrobial susceptibility of Acinetobacter baumannii isolates obtained from two hospital outbreaks in Los Angeles County, California, USA

BMC Infectious Diseases

Volumn 16, Issue 1, 2016, Pages

  Warner, Wayne A ^a   Kuang, Shan N ^a   Hernandez, Rina ^a   Chong, Melissa C ^a   Ewing, Peter J ^a   Fleischer, Jen ^a   Meng, Jia ^a   Chu, Sheena ^b   Terashita, Dawn ^c   English, L'Tanya ^c   Chen, Wangxue ^d   Xu, H Howard ^a  

^a CALIFORNIA STATE UNIVERSITY   (United States)

^b Public Health Laboratory   (United States)

^c Los Angeles County Department of Public Health   (United States)

^d NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Acinetobacter baumannii; Antimicrobial susceptibility; Epidemiology; Mechanism of resistance; Nosocomial outbreak

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BACTERIAL DNA; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; GATIFLOXACIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN; POLYMYXIN B; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; BETA-LACTAMASE OXA-23, ACINETOBACTER BAUMANNII; BETA-LACTAMASE OXA-24; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BINDING AFFINITY; BLA OXA 23 GENE; BROTH DILUTION; CLONE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA SEQUENCE; GENE CASSETTE; GYRA GENE; HOSPITAL INFECTION; INTEGRON; ISABA1 GENE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PARC GENE; POINT MUTATION; POLYMERASE CHAIN REACTION; PROTEIN BINDING; PROTEIN TARGETING; PULSED FIELD GEL ELECTROPHORESIS; UNITED STATES; ACINETOBACTER INFECTIONS; CALIFORNIA; CROSS INFECTION; DRUG EFFECTS; EPIDEMIC; GENETICS; HUMAN; INTENSIVE CARE UNIT; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CALIFORNIA; CROSS INFECTION; DISEASE OUTBREAKS; DNA GYRASE; DNA TOPOISOMERASE IV; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; HUMANS; INTEGRONS; INTENSIVE CARE UNITS; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING;

EID: 84965057354     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-016-1526-y     Document Type: Article

References (61)

1. Decousser JW, Jansen C, Nordmann P, Emirian A, Bonnin RA, Anais L, et al. Outbreak of NDM-1-producing Acinetobacter baumannii in France, January to May 2013. Euro Surveill. 2013;18(31):20547.
2. Vilacoba E, Almuzara M, Gulone L, Rodriguez R, Pallone E, Bakai R, Centron D, Ramirez MS. Outbreak of extensively drug-resistant Acinetobacter baumannii indigo-pigmented strains. J Clin Microbiol. 2013;51(11):3726-30.
3. Zarrilli R, Di Popolo A, Bagattini M, Giannouli M, Martino D, Barchitta M, Quattrocchi A, Iula VD, de Luca C, Scarcella A, et al. Clonal spread and patient risk factors for acquisition of extensively drug-resistant Acinetobacter baumannii in a neonatal intensive care unit in Italy. J Hosp Infect. 2012;82(4):260-5.
4. Zarrilli R, Pournaras S, Giannouli M, Tsakris A. Global evolution of multidrug-resistant acinetobacter baumannii clonal lineages. Int J Antimicrob Agents. 2013;41(1):11-9.
5. Durante-Mangoni E, Utili R, Zarrilli R. Combination therapy in severe Acinetobacter baumannii infections: an update on the evidence to date. Future Microbiol. 2014;9(6):773-89.
6. Peng C, Zong Z, Fan H. Acinetobacter baumannii isolates associated with community-acquired pneumonia in West China. Clin Microbiol Infect. 2012;18(12):E491-493.
7. Solak Y, Atalay H, Turkmen K, Biyik Z, Genc N, Yeksan M. Community-acquired carbapenem-resistant Acinetobacter baumannii urinary tract infection just after marriage in a renal transplant recipient. Transpl Infect Dis. 2011;13(6):638-40.
8. Chen MZ, Hsueh PR, Lee LN, Yu CJ, Yang PC, Luh KT. Severe community-acquired pneumonia due to Acinetobacter baumannii. Chest. 2001;120(4):1072-7.
9. Eveillard M, Kempf M, Belmonte O, Pailhories H, Joly-Guillou ML. Reservoirs of Acinetobacter baumannii outside the hospital and potential involvement in emerging human community-acquired infections. Int J Infect Dis. 2013;17(10):e802-805.
10. Falagas ME, Karveli EA, Kelesidis I, Kelesidis T. Community-acquired Acinetobacter infections. Eur J Clin Microbiol Infect Dis. 2007;26(12):857-68.
11. Ozaki T, Nishimura N, Arakawa Y, Suzuki M, Narita A, Yamamoto Y, Koyama N, Nakane K, Yasuda N, Funahashi K. Community-acquired Acinetobacter baumannii meningitis in a previously healthy 14-month-old boy. J Infect Chemother. 2009;15(5):322-4.
12. Fournier PE, Vallenet D, Barbe V, Audic S, Ogata H, Poirel L, Richet H, Robert C, Mangenot S, Abergel C, et al. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet. 2006;2(1):e7.
13. Valencia R, Arroyo LA, Conde M, Aldana JM, Torres MJ, Fernandez-Cuenca F, Garnacho-Montero J, Cisneros JM, Ortiz C, Pachon J, et al. Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care University Hospital. Infect Control Hosp Epidemiol. 2009;30(3):257-63.
14. Valentine SC, Contreras D, Tan S, Real LJ, Chu S, Xu HH. Phenotypic and molecular characterization of Acinetobacter baumannii clinical isolates from nosocomial outbreaks in Los Angeles county. California J Clin Microbiol. 2008;46(8):2499-507.
15. Bahador A, Taheri M, Pourakbari B, Hashemizadeh Z, Rostami H, Mansoori N, Raoofian R. Emergence of rifampicin, tigecycline, and colistin-resistant Acinetobacter baumannii in Iran; spreading of MDR strains of novel international clone variants. Microb Drug Resist. 2013;19(5):397-406.
16. Llaca-Diaz JM, Mendoza-Olazaran S, Camacho-Ortiz A, Flores S, Garza-Gonzalez E. One-year surveillance of ESKAPE pathogens in an intensive care unit of Monterrey. Mexico Chemotherapy. 2012;58(6):475-81.
17. Akers KS, Mende K, Yun HC, Hospenthal DR, Beckius ML, Yu X, Murray CK. Tetracycline susceptibility testing and resistance genes in isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus complex from a U.S. military hospital. Antimicrob Agents Chemother. 2009;53(6):2693-5.
18. Hujer KM, Hujer AM, Hulten EA, Bajaksouzian S, Adams JM, Donskey CJ, Ecker DJ, Massire C, Eshoo MW, Sampath R, et al. Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. Isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob Agents Chemother. 2006;50(12):4114-23.
19. Kang G, Hartzell JD, Howard R, Wood-Morris RN, Johnson MD, Fraser S, et al. Mortality associated with Acinetobacter baumannii complex bacteremia among patients with war-related trauma. Infect Control Hosp Epidemiol. 2010;31(1):92-4.
20. Zapor MJ, Moran KA. Infectious diseases during wartime. Curr Opin Infect Dis. 2005;18(5):395-9.
21. Huang XZ, Chahine MA, Frye JG, Cash DM, Lesho EP, Craft DW, Lindler LE, Nikolich MP. Molecular analysis of imipenem-resistant Acinetobacter baumannii isolated from US service members wounded in Iraq, 2003-2008. Epidemiol Infect. 2012;140(12):2302-7.
22. Taitt CR, Leski TA, Stockelman MG, Craft DW, Zurawski DV, Kirkup BC, Vora GJ. Antimicrobial resistance determinants in Acinetobacter baumannii isolates taken from military treatment facilities. Antimicrob Agents Chemother. 2014;58(2):767-81.
23. Harris G, Kuo Lee R, Lam CK, Kanzaki G, Patel GB, Xu HH, Chen W. A mouse model of Acinetobacter baumannii--associated pneumonia using a clinically isolated hypervirulent strain. Antimicrob Agents Chemother. 2013;57(8):3601-13.
24. Ou HY, Kuang SN, He X, Molgora BM, Ewing PJ, Deng Z, Osby M, Chen W, Xu HH. Complete genome sequence of hypervirulent and outbreak-associated Acinetobacter baumannii strain LAC-4: epidemiology, resistance genetic determinants and potential virulence factors. Sci Rep. 2015;5:8643.
25. Golanbar GD, Lam CK, Chu YM, Cueva C, Tan SW, Silva I, Xu HH. Phenotypic and molecular characterization of Acinetobacter clinical isolates obtained from inmates of California correctional facilities. J Clin Microbiol. 2011;49(6):2121-31.
26. Chang HC, Wei YF, Dijkshoorn L, Vaneechoutte M, Tang CT, Chang TC. Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region. J Clin Microbiol. 2005;43(4):1632-9.
27. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33(9):2233-9.
28. Turton JF, Gabriel SN, Valderrey C, Kaufmann ME, Pitt TL. Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii. Clin Microbiol Infect. 2007;13(8):807-15.
29. Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S. The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One. 2010;5(4):e10034.
30. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved Standard - Ninth Edition. Wayne, PA, USA: CLSI document M07-A9; 2012.
31. Vila J, Ruiz J, Goni P, de Anta TJ. Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii. J Antimicrob Chemother. 1997;39(6):757-62.
32. Vila J, Ruiz J, Goni P, Marcos A, Jimenez de anta T. Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother. 1995;39(5):1201-3.
33. Ploy MC, Denis F, Courvalin P, Lambert T. Molecular characterization of integrons in Acinetobacter baumannii: description of a hybrid class 2 integron. Antimicrob Agents Chemother. 2000;44(10):2684-8.
34. Levesque C, Piche L, Larose C, Roy PH. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob Agents Chemother. 1995;39(1):185-91.
35. Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, Amyes SG, Livermore DM. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents. 2006;27(4):351-3.
36. Segal H, Garny S, Elisha BG. Is IS(ABA-1) customized for Acinetobacter? FEMS Microbiol Lett. 2005;243(2):425-9.
37. Huang XZ, Frye JG, Chahine MA, Cash DM, Barber MG, Babel BS, Kasper MR, Whitman TJ, Lindler LE, Bowden RA, et al. Genotypic and phenotypic correlations of multidrug-resistant Acinetobacter baumannii-A. Calcoaceticus complex strains isolated from patients at the national naval medical center. J Clin Microbiol. 2010;48(11):4333-6.
38. Seifert H, Dolzani L, Bressan R, van der Reijden T, van Strijen B, Stefanik D, Heersma H, Dijkshoorn L. Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J Clin Microbiol. 2005;43(9):4328-35.
39. Maiden MC. Multilocus sequence typing of bacteria. Annu Rev Microbiol. 2006;60:561-88.
40. Hammerum AM, Hansen F, Skov MN, Stegger M, Andersen PS, Holm A, Jakobsen L, Justesen US. Investigation of a possible outbreak of carbapenem-resistant Acinetobacter baumannii in Odense, Denmark using PFGE, MLST and whole-genome-based SNPs. J Antimicrob Chemother. 2015;70(7):1965-8.
41. Lee HY, Huang CW, Chen CL, Wang YH, Chang CJ, Chiu CH. Emergence in Taiwan of novel imipenem-resistant acinetobacter baumannii ST455 causing bloodstream infection in critical patients. J Microbiol Immunol Infec. 2015;48(6):588-96.
42. Alvargonzalez JJ, Vindel Hernando A, Martin MD, Casas CM, Iglesias JO, Marin MF, Alvarez ML, Sanchez VB, Mari JM. Sequential outbreaks in a Spanish hospital caused by multiresistant OXA-58-producing Acinetobacter baumannii ST92. J Med Microbiol. 2014;63(Pt 8):1093-8.
43. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement. Wayne, PA, USA: CLSI document M100-S22; 2012.
44. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268-81.
45. Miyasaki Y, Morgan MA, Chan RC, Nichols WS, Hujer KM, Bonomo RA, Murthy AR. In vitro activity of antibiotic combinations against multidrug-resistant strains of Acinetobacter baumannii and the effects of their antibiotic resistance determinants. FEMS Microbiol Lett. 2012;328(1):26-31.
46. Luo G, Lin L, Ibrahim AS, Baquir B, Pantapalangkoor P, Bonomo RA, Doi Y, Adams MD, Russo TA, Spellberg B. Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection. PLoS One. 2012;7(1):e29446.
47. Piddock LJ. Mechanisms of fluoroquinolone resistance: an update 1994-1998. Drugs. 1999;58 Suppl 2:11-8.
48. Gu DX, Hu YJ, Zhou HW, Zhang R, Chen GX. Substitutions of Ser83Leu in GyrA and Ser80Leu in ParC associated with quinolone resistance in Acinetobacter pittii. Microb Drug Resist. 2015;21(3):345-51.
49. Ramirez MS, Tolmasky ME. Aminoglycoside modifying enzymes. Drug Resist Updat. 2010;13(6):151-71.
50. Shaw KJ, Rather PN, Hare RS, Miller GH. Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol Rev. 1993;57(1):138-63.
51. Domingues S, da Silva GJ, Nielsen KM. Integrons: vehicles and pathways for horizontal dissemination in bacteria. Mob Genet Elements. 2012;2(5):211-23.
52. Recchia GD, Hall RM. Origins of the mobile gene cassettes found in integrons. Trends Microbiol. 1997;5(10):389-94.
53. Sung JY, Koo SH, Kim S, Kwon KC. Epidemiological characterizations of class 1 integrons from multidrug-resistant acinetobacter isolates in Daejeon. Korea Ann Lab Med. 2014;34(4):293-9.
54. Lin MF, Liou ML, Tu CC, Yeh HW, Lan CY. Molecular epidemiology of integron-associated antimicrobial gene cassettes in the clinical isolates of Acinetobacter baumannii from Northern Taiwan. Ann Lab Med. 2013;33(4):242-7.
55. Saule M, Samuelsen O, Dumpis U, Sundsfjord A, Karlsone A, Balode A, Miklasevics E, Karah N. Dissemination of a carbapenem-resistant Acinetobacter baumannii strain belonging to international clone II/sequence type 2 and harboring a novel AbaR4-like resistance island in Latvia. Antimicrob Agents Chemother. 2013;57(2):1069-72.
56. Srinivasan VB, Rajamohan G, Pancholi P, Stevenson K, Tadesse D, Patchanee P, Marcon M, Gebreyes WA. Genetic relatedness and molecular characterization of multidrug resistant Acinetobacter baumannii isolated in central Ohio. USA Ann Clin Microbiol Antimicrob. 2009;8:21.
57. Lemos EV, de la Hoz FP, Einarson TR, McGhan WF, Quevedo E, Castaneda C, Kawai K. Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis. Clin Microbiol Infect. 2014;20(5):416-23.
58. Salimizand H, Noori N, Meshkat Z, Ghazvini K, Amel SJ. Prevalence of Acinetobacter baumannii harboring ISAba1/blaOXA-23-like family in a burn center. Burns. 2015;41(5):1100-6.
59. Chagas TP, Carvalho KR, de Oliveira Santos IC, Carvalho-Assef AP, Asensi MD. Characterization of carbapenem-resistant Acinetobacter baumannii in Brazil (2008-2011): countrywide spread of OXA-23-producing clones (CC15 and CC79). Diagn Microbiol Infect Dis. 2014;79(4):468-72.
60. Agodi A, Voulgari E, Barchitta M, Quattrocchi A, Bellocchi P, Poulou A, Santangelo C, Castiglione G, Giaquinta L, Romeo MA, et al. Spread of a carbapenem- and colistin-resistant Acinetobacter baumannii ST2 clonal strain causing outbreaks in two Sicilian hospitals. J Hosp Infect. 2014;86(4):260-6.
61. Teo J, Lim TP, Hsu LY, Tan TY, Sasikala S, Hon PY, Kwa AL, Apisarnthanarak A. Extensively drug-resistant Acinetobacter baumannii in a Thai hospital: a molecular epidemiologic analysis and identification of bactericidal Polymyxin B-based combinations. Antimicrob Resist Infect Control. 2015;4(1):2.